Theriva Biologics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $154 |
Gross Profit | -27 | -26 | -27 | |
EBITDA | -4,333 | -13,105 | -4,370 | -4,420 |
EBIT | -4,361 | -13,132 | -4,396 | -4,447 |
Net Income | -4,361 | -13,058 | -4,324 | -4,447 |
Net Change In Cash | 0 | 0 | 0 | 154 |
Free Cash Flow | -4,338 | -4,728 | -4,756 | -4,691 |
Cash | 7,528 | 12,120 | 10,014 | 11,609 |
Basic Shares | 9,676 | 6,752 | 2,782 | 1,348 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -137 | -135 | -268 | -87 |
EBITDA | -19,290 | -21,956 | -19,205 | -14,187 |
EBIT | -19,427 | -22,091 | -19,290 | -14,274 |
Net Income | -25,653 | -18,349 | -19,685 | -14,174 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,938 | -19,198 | -19,198 | -12,904 |
Cash | 11,609 | 23,177 | 41,786 | 67,325 |
Basic Shares | 1,348 | 644 | 613 | 12,187 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.45 |
2025-06-30 | -$1.93 |
2025-03-31 | -$1.55 |
2024-12-31 | -$11.49 |
